Trials / Completed
CompletedNCT02698943
Glistenings and PCO Evaluation for the Envista MX60
Evaluation of Glistenings and Posterior Capsule Opacification Following Envista MX60 Intraocular Lens Implantation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Democritus University of Thrace · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Posterior capsule opacification (PCO) and glistenings development is among the primary reasons for sub-optimal visual capacity following cataract extraction surgery. Primary objective of this study is to evaluate the incidence of PCO and glistenings of the popular envista MX-60 intraocular lens (Bausch + Lomb) in a random sample of cataract patients who underwent phacoemulsification at least 1 year prior to their enrollment at the study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Phacoemulsification | Phacoemulsification for cataract extraction with Envista MX-60 implantation |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2016-03-04
- Last updated
- 2016-03-04
Source: ClinicalTrials.gov record NCT02698943. Inclusion in this directory is not an endorsement.